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0.9, respectively. The scores of cartilage damage in the BMP-M group
were less severe than PBS group. The histological severity of OA in BMP-M
group was signiﬁcantly lower than PBS and BMP-S group according to
the modiﬁed Mankin’s histological grading. Remarkable inﬂammation or
hyperplasia of synovium was not observed in any group.
Conclusions: Local administration of therapeutic agents to joints is
reasonable in OA which is not systemic disease. The osmotic pumps
were previously used for the maintenance of effective concentration of
therapeutic agents in the joint of animal experiments. Biodegradable
GHM was reported to achieve controlled release of growth factors in the
condition that maintained the biological activity of growth factors. The
present study showed this sustained releasing system of BMP-7 in the
joint had protective effects on OA development in an animal model. This
method might be a useful conservative treatment for human OA in the
future.
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Fig. 1. In vivo release kinematics of BMP-7.
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Fig. 2. Gross morphological evaluation (score).
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A SHORT TIME WINDOW TO PROFIT FROM IL-4 PLUS IL-10 ADDITION
TO PROTECT CARTILAGE FROM BLOOD-INDUCED DAMAGE IN VITRO
M.E. van Meegeren1,2, N.W. Jansen1,2, G. Roosendaal2, S.C. Mastbergen1,
F.P. Lafeber1. 1Rheumatology & Clinical Immunology, Univ. Med. Ctr.
Utrecht, Utrecht, Netherlands; 2Hematology and Van Creveld Clinic, Univ.
Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Exposure of joint cartilage to blood can occur after joint trauma,
during or after major joint surgery, or due to hemophilia. This ultimately
leads to joint damage, having both the inﬂammatory characteristics
of rheumatoid arthritis and the degenerative characteristics of
osteoarthritis. It has been reported that interleukin (IL)-10 limits blood-
induced cartilage damage in vitro and that IL-4 has some cartilage
protective properties. Our aim was to study whether the combination
of IL-4 and IL-10 has an additive effect on prevention of blood-induced
cartilage damage when administered during (prevention) and after the
onset (treatment) of blood-exposure.
Methods: Human full thickness articular cartilage explants were cultured
for 4 days in the presence or absence of 50% v/v homologous blood,
mimicking a joint bleed. Either IL-4 or IL-10 alone was added (0, 10,
30, or 100ng/ml) during blood exposure (n =9 donors). Additionally,
a combination of IL-4 and IL-10 was added during blood exposure
(prevention), as well as 2, 4, 8, 24, or 48 hours after start of blood-
exposure (treatment) (n = 5 donors). After 4 days of culture the medium
was refreshed and cartilage was cultured for an additional 12 days in
the absence of additives to determine long-term effects of short-term
blood-exposure and treatment. This mimics the in vivo situation where
blood is cleared from a joint within approximately 4 days and where
IL-4 and IL-10 have short half live times. Cartilage matrix turnover, in
terms of proteoglycan synthesis, -release, and -content, was determined
at day 16.
Results: Cartilage cultured in the presence of blood decreased
proteoglycan synthesis rate, increased proteoglycan release, and
decreased proteoglycan content as measured after 16 days of culture (all
p < 0.05). This blood-induced damage to the cartilage matrix was limited
both by IL-10 and IL-4 alone in a dose-dependent way. At 10ng/ml,
IL-10 and IL-4 improved proteoglycan synthesis rate with 41% and 125%,
respectively; proteoglycan release decreased with 42% and 59%, and
proteoglycan content increased both with 19% (all p< 0.05 compared to
blood-exposure).
Most importantly, the combination of IL-4 and IL-10 (10ng/ml) was
more protective against damage caused by blood than IL-10 alone. The
decrease of proteoglycan synthesis rate due to exposure to blood was
further improved with 157%, and proteoglycan release decreased with
59% (both p < 0.05 compared to IL-10 alone).
When IL-4 plus IL-10 were added after the onset of blood-exposure, it
appeared that it had to be administered within 8 hours after start of
the bleeding to still be able to protect against blood-induced cartilage
damage. At later time points addition was ineffective.
Conclusions: Besides IL-10, as shown previously, also IL-4 protects
against blood-induced cartilage damage. This study demonstrates that
the combination of IL-4 and IL-10 is clearly more effective than the
individual components. Importantly, the protective effect is only evident
when IL-4 and Il-10 are added within 8 hours after start of blood-
exposure. This implies that treatment should be started within this time
span to prevent blood-induced cartilage damage as a result of trauma or
surgery.
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ENCAPSULATION IN ALGINATE BEADS RETAINS LONG-TERM
IMMUNOMODULATORY PROPERTIES OF BONE MARROW
MESENCHYMAL STEM CELLS
E. Villafuertes1,2, G.M. van Buul2,3, N. Kops2, B. Fernandez-Gutierrez1,
J.A. Verhaar2, M.J. Hoogduijn4, G.J. van Osch2,5. 1Rheumatology Service.
Hosp. Clinico San Carlos de Madrid., Madrid, Spain; 2Dept. of Orthopaedics,
Erasmus MC, Rotterdam, Netherlands; 3Dept. of Radiology, Erasmus MC,
Rotterdam, Netherlands; 4Dept. of Internal Med., Erasmus MC, Rotterdam,
Netherlands; 5Dept. of Otorhinolaryngology, Erasmus MC, Rotterdam,
Netherlands
Purpose: Mesenchymal stem cells (MSCs) are a source of pluripotent
cells. They are able to self renew, differentiate into cells of mesoderm
lineage and modulate the immune response. Here we focus on
the immunomodulatory properties of MSCs for therapeutic use in
osteoarthritis. We studied the possibility to encapsulate MSCs in
alginate beads in order to achieve long-term immunomodulatory activity
of MSCs and to place them in the jointcavity. We evaluated the
expression of immunomodulatory factors by MSC upon stimulation
with inﬂammatory factors when encapsulated in alginate compared
to monolayer. Furthermore we studied the survival and differentiation
capacity of MSCs after long-term encapsulation in alginate.
Methods: Human bone marrow MSCs of two different donors were
encapsulated in 1.2% alginate or seeded in monolayer and after
preconditioning for 48 hours they were stimulated by cytokines
(50ng/mL IFNg, 50 ng/mL TNFa) for 24 hours. Each experiment was
performed in triplicate. We studied the gene expression of MSCs
compared to unstimulated control cultures. To evaluate the behavior
after long-term encapsulation the above experiment was repeated after
30 days of preculture in alginate. We also measured the amount of
DNA in a time course experiment and evaluated MSCs multi-lineage
differentiation capacities after 1 and 30 days of encapsulation in alginate
beads. Mixed model ANOVA was used to calculate statistical signiﬁcance.
A p-value <0.05 was considered statistically signiﬁcance.
Results: Stimulation with IFNg and TNFa increased the expression of
TNFa, IL1b, IL-6 (Fig1A), IDO (Fig1B) and COX2 in MSCs, whereas VEGF
was downregulated (p < 0.05). TGFb1 and TIMP2 didn’t reach signiﬁcance
but showed a trend toward downregulation after cytokine treatment.
The response of MSCs in alginate was similar to MSCs in monolayer
culture. After 30 days in alginate the amount of DNA/alginate bead was
unchanged, suggesting MSCs survive but do not proliferate in alginate.
The cells still responded to inﬂammatory cytokines by increasing the
expression of TNFa, IL1b, IL-6 (Fig1A), IDO (Fig 1B) and COX2 and
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reducing the expression of VEGF, TGFb1, TIMP1 and TIMP2 (p < 0.05).
After encapsulation in alginate for 1 or 30 days the cells were able to
differentiate in adipogenic and osteogenic lineage although after 30 days
in alginate beads these capacities were diminished.
Conclusion: MSCs maintain their immunomodulatory properties after
encapsulation in alginate beads even after 30 days, although their
differentiation capacities were reduced. These results support the
possibility of a safe and durable way of immune modulation in the
joint by introduction of MSCs encapsulated in alginate beads.
Fig. 1. MSCs gene expression of IL6 and IDO after cytokine stimulation in
monolayer, alginate beads after 48 hours preconditioning and alginate
beads after 30 days preconditioning cultures. BKI, best keeper index:
GAPDH, UBC, HPRT. ***p < 0.001; ****p < 0.0001.
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THE EXPRESSION OF TYPE2 COLLAGEN IS REGULATED BY PTEN IN
CHONDROCYTES
K. Iwasa, T. Nishiyama, S. Hayashi, T. Fujishiro, N. Kanzaki, K. Takebe,
K. Kawakita, R. Kuroda, M. Kurosaka. Kobe Univ. Graduate Sch., Kobe,
Japan
Purpose: Phosphatase and tensin homologue deleted on chromosome
10 (PTEN) was identiﬁed as an important tumor suppressor gene. PTEN
is second most frequently mutated gene in human cancer after p53. The
function of PTEN is one of negative regulator of phosphoinositol-3-kinase
(PI3K) signaling. PI3K pathway is critical for cell survival, differentiation
and matrix synthesis. We have reported that apoptosis by shear stress
in chondrocytes was dependent on p53, but the functions of PTEN in
chondrocytes are still unknown. Therefore, we investigated the function
of PTEN in chondrocytes.
Methods: NHAC-kn cells (normal human articular chondrocyte – knee)
were used for normal chondrocytes. Chondrocytes were cultured on
silicone chambers (STREX, Osaka, Japan), and stretched at 5% and 10%
stress for 24hours by pulse-motor-driven stretch machine (STREX, Osaka,
Japan). In order to inhibit the function of PTEN, PTEN siRNA was
transfected to NHAC-kn cells by lipofection method. After tranfection of
PTEN siRNA, NHAC-kn cells were applied 5% stretch stress for 24hours.
Further, chondrocytes were pretreated with PI3K speciﬁc inhibitor
(LY294002) and were applied at 5% stretch stress for 24hours.
The expressions of PTEN, p53 and type2 collagen (Col2) mRNA were
analyzed by real-time PCR. The expressions of Akt and phosphorylation
of Akt (pAkt) were analyzed by Western blotting.
Results: The expression levels of p53 were increased by stretch stress
in a stress dependent manner, but those of PTEN were not changed
(Figure 1). The expressions of Col2 were increased by 5% stretch stress,
but were decreased by 10% stretch stress (Figure 2).
After transfection of PTEN siRNA, the expressions of Col2 were increased
and were much more increased when 5% stretch stress was applied in
comparsion with control siRNA(Figure 3).
The expressions of pAkt were inceased after transfection of PTEN siRNA,
and were completely blocked by LY294002. The expressions of Col2 were
inhibited after exposure to LY294002.
Conclusions: PTEN is one of the most important tumor suppressor like
p53. We have reported that p53 was increased by shear stress, but
PTEN was not increased. The function of PTEN depends on its abundant
expression. However, p53 acts emergently when DNA is damaged. It
might be thought that the roles in chondrocytes were different between
PTEN and p53.
Zhang reported that Col2 expression was regulated via PI3K/Akt pathway.
We conﬁrmed that the expressions of Col2 were decreased with
attenuation of Akt phosphorylation when PI3K activity was blocked
by LY294002. Down-regulation of PTEN expression increased Col2
expression with activation of Akt phosphorylation. Therefore, PTEN
regulates the expressions of Col2 by inhibition of Akt phosphorylation.
In conclusion, PTEN might have an important role in cartilage repair by
regulation of Col2.
Fig. 1.
Fig. 2.
Fig. 3.
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ACID CERAMIDASE IMPROVES THE CHONDROGENIC PHENOTYPE OF
PRIMARY AND MESENCHYMAL STEM CELL-DERIVED CHONDROCYTES:
IMPLICATIONS FOR CARTILAGE REPAIR
C.M. Simonaro, S. Sachot, E. Eliyahu, H. Sun, E. Schuchman. Mount Sinai
Sch. of Med., NY, NY, USA
Background and Purpose: Acid ceramidase is a key regulatory enzyme
required to maintain the critical balance between the pro-apoptotic
signaling lipid, ceramide, and the pro-survival lipid, sphingosine-
1-phosphate (S1P). Several recent reports have demonstrated the
importance of this lipid-signaling pathway for normal cartilage
homeostasis, and abnormalities in this pathway have been associated
with several degenerative cartilage diseases. The purpose of this
study was therefore to evaluate the effects of human recombinant
acid ceramidase (rAC) on the growth and phenotype of primary and
mesenchymal stem cell (MSC)-derived chondrocytes, and its potential
use in cartilage repair.
Methods: Primary articular chondrocytes were grown with and without
rAC, and the expression of several chondrogenic markers were analyzed
by western blotting, immunohistochemistry, and/or qPCR. Safranin-O and
Alcian Blue staining also was performed. Similar studies were performed
using bone marrow cells, and the effects of rAC on the production and
